Inventor

LINSLEY PETER S

US66 patents

⚠️ This page may combine multiple inventors who share the name “LINSLEY PETER S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LINSLEY PETER S

BRISTOL MYERS SQUIBB CO

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

CTLA4/CD28Ig hybrid fusion proteins and uses thereof

CTLA4 receptor and uses thereof

CTLA4 receptor and uses thereof

CTLA4 receptor and uses thereof

CTLA4 receptor and uses thereof

Soluble CTLA4 molecules and uses thereof

CTLA4 Ig fusion proteins

MYPPPY variants of CTL A4 and uses thereof

B7Ig fusion protein

CD28IG fusion protein

Chimeric CTLA4 receptor and methods for its use

Method of regulating cellular processes mediated by B7 and CD28

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith

Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules

Mixed specificity fusion proteins

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

Soluble CTLA4 mutant molecules

Methods for treating immune system diseases using a soluble CTLA4 molecule

Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions

Method to inhibit T cell interactions with soluble B7

Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand

Soluble CTLA4 mutant molecules and uses thereof

Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen

Monoclonal antibodies and FV specific for CD2 antigen

Monoclonal antibodies and FV specific for CD2 antigen

Methods for blocking binding of CD28 receptor to B7

Method for generating and identifying antibodies directed against a B7

Methods of treatment using CTLA4 mutant molecules

Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules

Inhibition of tumor cell growth by administration of B7-transfected cells

Anti-oncostatin M monoclonal antibodies

Methods of treatment using CTLA4 mutant molecules

Method of inhibiting immune system destruction of transplanted viable cells

Methods of treatment using CTLA4 mutant molecules

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

Soluble CTLA4 mutant molecules

ROSETTA INPHARMATICS LLC

Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays

Diagnosis and prognosis of breast cancer patients

NETHERLANDS CANCER INST

Methods of assigning treatment to breast cancer patients

Diagnosis and prognosis of breast cancer patients

ROSETTA INPHARMATICS INC

RNA amplification method

Monitoring of gene expression by detecting hybridization to nucleic acid arrays using anti-heteronucleic acid antibodies

DHARMACON INC

Modified polynucleotides for reducing off-target effects in RNA interference

SANOFI SA

Hybridomas producing monoclonal antibodies to new mucin epitopes

HUTCHINSON FRED CANCER RES

Genes associated with progression and response in chronic myeloid leukemia and uses thereof

CETUS CORP

Assay for human breast cancer